Continuous electroencephalogram(cEEG)has become an indispensable technique in the management of critically ill patients for early detection and treatment of non-convulsive seizures(NCS)and non-convulsive status epilep...Continuous electroencephalogram(cEEG)has become an indispensable technique in the management of critically ill patients for early detection and treatment of non-convulsive seizures(NCS)and non-convulsive status epilepticus(NCSE).It has also brought about a renaissance in a wide range of rhythmic and periodic patterns with heterogeneous frequency and morphology.These patterns share the rhythmic and sharp appearances of electrographic seizures,but often lack the necessary frequency,spatiotemporal evolution and clinical accompaniments to meet the definitive criteria for ictal patterns.They may be associated with cerebral metabolic crisis and neuronal injury,therefore not clearly interictal either,but lie along an intervening spectrum referred to as ictal-interictal continuum(IIC).Generally speaking,rhythmic and periodic patterns are categorized as interictal patterns when occurring at a rate of<1Hz,and are categorized as NCS and NCSE when occurring at a rate of>2.5 Hz with spatiotemporal evolution.As such,IIC commonly includes the rhythmic and periodic patterns occurring at a rate of 1–2.5 Hz without spatiotemporal evolution and clinical correlates.Currently there are no evidence-based guidelines on when and if to treat patients with IIC patterns,and particularly how aggressively to treat,presenting a challenging electrophysiological and clinical conundrum.In practice,a diagnostic trial with preferably a non-sedative anti-seizure medication(ASM)can be considered with the end point being both clinical and electrographic improvement.When available and necessary,correlation of IIC with biomarkers of neuronal injury,such as neuronal specific enolase(NSE),neuroimaging,depth electrode recording,cerebral microdialysis and oxygen measurement,can be assessed for the consideration of ASM treatment.Here we review the recent advancements in their clinical significance,risk stratification and treatment algorithm.展开更多
基金the Capital Healthy Development ResearchFunding 2020–1-2013 and 2016–1-2011.
文摘Continuous electroencephalogram(cEEG)has become an indispensable technique in the management of critically ill patients for early detection and treatment of non-convulsive seizures(NCS)and non-convulsive status epilepticus(NCSE).It has also brought about a renaissance in a wide range of rhythmic and periodic patterns with heterogeneous frequency and morphology.These patterns share the rhythmic and sharp appearances of electrographic seizures,but often lack the necessary frequency,spatiotemporal evolution and clinical accompaniments to meet the definitive criteria for ictal patterns.They may be associated with cerebral metabolic crisis and neuronal injury,therefore not clearly interictal either,but lie along an intervening spectrum referred to as ictal-interictal continuum(IIC).Generally speaking,rhythmic and periodic patterns are categorized as interictal patterns when occurring at a rate of<1Hz,and are categorized as NCS and NCSE when occurring at a rate of>2.5 Hz with spatiotemporal evolution.As such,IIC commonly includes the rhythmic and periodic patterns occurring at a rate of 1–2.5 Hz without spatiotemporal evolution and clinical correlates.Currently there are no evidence-based guidelines on when and if to treat patients with IIC patterns,and particularly how aggressively to treat,presenting a challenging electrophysiological and clinical conundrum.In practice,a diagnostic trial with preferably a non-sedative anti-seizure medication(ASM)can be considered with the end point being both clinical and electrographic improvement.When available and necessary,correlation of IIC with biomarkers of neuronal injury,such as neuronal specific enolase(NSE),neuroimaging,depth electrode recording,cerebral microdialysis and oxygen measurement,can be assessed for the consideration of ASM treatment.Here we review the recent advancements in their clinical significance,risk stratification and treatment algorithm.